Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Notices:
Notice of Availability of Frequently Asked Questions for PAR-16-300 "Clinical
Coordinating Center for Multi-Site Investigator Clinical Trials (Collaborative
UG3/UH3)"
(NOT-HL-16-448)
National Heart, Lung, and Blood Institute
Coordinating Center for Multi-Site Investigator Clinical Trials (Collaborative
UG3/UH3)"
(NOT-HL-16-448)
National Heart, Lung, and Blood Institute
Notice of Availability of Frequently Asked Questions for PAR-16-301 "Data
Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials
(Collaborative U24)"
(NOT-HL-16-449)
National Heart, Lung, and Blood Institute
Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials
(Collaborative U24)"
(NOT-HL-16-449)
National Heart, Lung, and Blood Institute
Notice of Availability of Frequently Asked Questions for PAR-16-405 "Single-Site
Investigator-Initiated Clinical Trials (R61/R33)"
(NOT-HL-16-450)
National Heart, Lung, and Blood Institute
Investigator-Initiated Clinical Trials (R61/R33)"
(NOT-HL-16-450)
National Heart, Lung, and Blood Institute
Requests for Applications:
Cardiovascular and Pulmonary Research on E-Cigarettes (R01)
(RFA-HL-17-021)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): January 17, 2017 and January 16, 2018, by 5:00
PM local time of applicant organization. All types of non-AIDS applications
allowed for this funding opportunity announcement are due on these dates.
(RFA-HL-17-021)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): January 17, 2017 and January 16, 2018, by 5:00
PM local time of applicant organization. All types of non-AIDS applications
allowed for this funding opportunity announcement are due on these dates.
Perinatal Stroke (R01)
(RFA-HL-18-002)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): February 7, 2017, by 5:00 PM local time of applicant
organization. All types of non-AIDS applications allowed for this funding
opportunity announcement are due on this date.
(RFA-HL-18-002)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): February 7, 2017, by 5:00 PM local time of applicant
organization. All types of non-AIDS applications allowed for this funding
opportunity announcement are due on this date.
Program Announcements:
Support of Competitive Research (SCORE) Pilot Project Award (SC2)
(PAR-16-438)
National Institute of General Medical Sciences
National Cancer Institute
National Heart, Lung, and Blood Institute
(PAR-16-438)
National Institute of General Medical Sciences
National Cancer Institute
National Heart, Lung, and Blood Institute
Support of Competitive Research (SCORE) Research Advancement Award
(SC1)
(PAR-16-439)
National Institute of General Medical Sciences
National Cancer Institute
National Heart, Lung, and Blood Institute
(SC1)
(PAR-16-439)
National Institute of General Medical Sciences
National Cancer Institute
National Heart, Lung, and Blood Institute
No hay comentarios:
Publicar un comentario